The Global Pneumatic Tourniquet Market size is expected to reach $654.9 million by 2031, rising at a market growth of 6.9% CAGR during the forecast period.
As healthcare systems in the Asia-Pacific region develop, there is a greater emphasis on improving patient safety and outcomes. These tourniquets are valued for their precision and ability to control blood flow, aligning with this focus on quality care. Consequently, the Asia Pacific region would acquire nearly 28% of the total market share by 2031.
As healthcare expenditures increase, hospitals and medical facilities can allocate additional resources to the acquisition of sophisticated medical technologies, such as these tourniquets. Higher healthcare expenditure often leads to expanding healthcare services, including the growth of surgical departments and specialized clinics. In conclusion, increased healthcare expenditure worldwide is driving the market's growth.
Additionally, Aging populations, chronic disease management, and patient preference for care at home drive the growing trend towards home healthcare. In addition, home healthcare provides patients with the comfort of being in a familiar environment. These tourniquets at home enhance patient convenience, allowing continuous care without frequent hospital visits. Therefore, expansion into home healthcare is propelling the growth of the market.
However, Advanced tourniquet systems often feature sophisticated technology and enhanced functionalities and come with higher price tags. Also, advanced tourniquet systems often require specialized maintenance and training, which can further increase the total cost of ownership. Thus, the high costs associated with advanced tourniquet systems hinder the market's growth.
Moreover, Regulatory processes for medical devices, including these tourniquets, faced delays due to the pandemic. These delays affected the introduction and approval of new products in the market. Manufacturers faced operational challenges due to lockdowns and restrictions, impacting their ability to maintain normal production schedules and meet market demand for these tourniquets. Thus, the COVID-19 pandemic had a negative impact on the market.
As healthcare systems in the Asia-Pacific region develop, there is a greater emphasis on improving patient safety and outcomes. These tourniquets are valued for their precision and ability to control blood flow, aligning with this focus on quality care. Consequently, the Asia Pacific region would acquire nearly 28% of the total market share by 2031.
As healthcare expenditures increase, hospitals and medical facilities can allocate additional resources to the acquisition of sophisticated medical technologies, such as these tourniquets. Higher healthcare expenditure often leads to expanding healthcare services, including the growth of surgical departments and specialized clinics. In conclusion, increased healthcare expenditure worldwide is driving the market's growth.
Additionally, Aging populations, chronic disease management, and patient preference for care at home drive the growing trend towards home healthcare. In addition, home healthcare provides patients with the comfort of being in a familiar environment. These tourniquets at home enhance patient convenience, allowing continuous care without frequent hospital visits. Therefore, expansion into home healthcare is propelling the growth of the market.
However, Advanced tourniquet systems often feature sophisticated technology and enhanced functionalities and come with higher price tags. Also, advanced tourniquet systems often require specialized maintenance and training, which can further increase the total cost of ownership. Thus, the high costs associated with advanced tourniquet systems hinder the market's growth.
Moreover, Regulatory processes for medical devices, including these tourniquets, faced delays due to the pandemic. These delays affected the introduction and approval of new products in the market. Manufacturers faced operational challenges due to lockdowns and restrictions, impacting their ability to maintain normal production schedules and meet market demand for these tourniquets. Thus, the COVID-19 pandemic had a negative impact on the market.
Driving and Restraining Factors
Drivers
- Increased healthcare expenditure worldwide
- Rising expansion into home healthcare
- Increasing number of surgical procedures globally
Restraints
- High costs associated with advanced pneumatic tourniquet systems
- Risk of complications and adverse effects
Opportunities
- Expansion of pneumatic tourniquets in veterinary surgeries
- Integration with advanced surgical robots
Challenges
- High competition from alternative haemostasis techniques
- Challenges of integration with existing systems
Application Outlook
On the basis of application, the market is segmented into orthopedic, intravenous regional anesthesia, and others. In 2023, the intravenous regional anesthesia segment attained 32% revenue share in the market. These tourniquets offer precise control over pressure, which is crucial for maintaining the desired level of blood flow restriction during IVRA.Type Outlook
Based on type, the market is divided into single bladder tourniquet and double bladder tourniquet. The double bladder tourniquet segment witnessed 36% revenue share in the market in 2023. Double bladder tourniquets offer superior haemostasis using two inflatable bladders within a single cuff. This design allows for more precise and uniform pressure distribution around the limb.Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed a 37% revenue share in the market in 2023. North America, especially the United States and Canada, has a highly developed healthcare infrastructure that strongly emphasizes advanced medical technologies and practices.List of Key Companies Profiled
- Ane-c Aid Ltd.
- Stryker Corporation
- VBM Medizintechnik GmbH
- Zimmer Biomet Holdings, Inc.
- SPENGLER HOLTEX Group
- Shanghai Huifeng Medical Instrument Co., Ltd.
- Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group)
- The Seaberg Company Inc. (SAM Medical)
- Hammarplast Medical AB
- OHK Medical Devices, Inc.
Market Report Segmentation
By Type
- Single Bladder Tourniquet
- Double Bladder Tourniquet
By Application
- Intravenous Regional Anesthesia
- Orthopedic
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Pneumatic Tourniquet Market by Type
Chapter 5. Global Pneumatic Tourniquet Market by Application
Chapter 6. Global Pneumatic Tourniquet Market by Region
Chapter 7. Company Profiles
Companies Mentioned
- Ane-c Aid Ltd.
- Stryker Corporation
- VBM Medizintechnik GmbH
- Zimmer Biomet Holdings, Inc.
- SPENGLER HOLTEX Group
- Shanghai Huifeng Medical Instrument Co., Ltd.
- Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group)
- The Seaberg Company Inc. (SAM Medical)
- Hammarplast Medical AB
- OHK Medical Devices, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 164 |
| Published | August 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 388.1 Million |
| Forecasted Market Value ( USD | $ 654.9 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
